Zach Erlichman, MDZach Erlichman, MD

Integrated Plastic Surgery Residency | Long Island, New York 2021 – 2027
Stony Brook University Hospital
Nassau University Medical Center
New York Plastic Surgical Group, PC

Resident (PGY-4)
Plastic Surgery

 


EDUCATION
Institution Degree End  Date
Tufts University School of Medicine Doctor of Medicine (M.D.) 2021
University of Wisconsin Bachelor of Science- Biology 2017

 

AWARDS & HONORS
Alpha Omega Alpha Honor Society 2021
Efficacy of Hemoblast in Plastic Surgery Grant, BiomUp 2020-2021
Harold Williams Scholarship 2018
University of Wisconsin Hilldale Research Scholarship 2014

 

PUBLICATIONS
Erlichman Z., Trentalange M., Ren T., Huston T., Krajewski A., Bui D., Khan S. Patient Reported Outcomes in Gynecomastia Surgery. In Submission.
Ren T., Galenchik A., Erlichman Z., Krajewski A. Prevalence of Regret in Gender-Affirming Surgery: A Systematic Review. Ann Plast Surg. 2024 May 1;92(5):597-602. doi: 10.1097/SAP.0000000000003895. PMID: 38685500.
Christopher L., Erlichman Z., Krajewski A., Khan F. Pubic Aneurysmal Bone Cyst Following Penile Inversion Vaginoplasty: A Case Report. Eplasty. 2024 April 3. 24:e15. ISSN 1937-5719
Erlichman, Z., Buro J., Mina V., Haritha V. Outcomes Using Two Unique Methods of Immediate Implant-Based Breast Reconstruction After Nipple-Sparing Mastectomy in Ptotic Patients. Ann Plast Surg. 2023 Feb 4. doi: 10.1097/SAP.0000000000003472. PMID: 36752524.
Bloom, J., Tian, T., Erlichman, Z., Char, S., Chatterjee, A., Homsy, C. The Current State of Oncoplastic Breast Surgery in Plastic and Reconstructive Surgery Training. Eplasty. 2022 Nov 2;22:e52. PMID: 37026035; PMCID: PMC10071595.
Char, S., Bloom, J., Erlichman, Z., Joncyzk, M., Chatterjee, A., Lifei G. How does oncoplastic surgery compare with standard partial mastectomy? A systemic review of patient reported outcomes. Plast Reconstr Surg. 2022 Nov 1;150(5):950e-958e. doi: 10.1097/PRS.0000000000009616.
Bloom, J., Erlichman, Z., Foroutanjazi, S., Beqiraj, Z., Jonczyk, M., Persing, S., Chatterjee, A. The Use of Hemostatic Agents to Decrease Bleeding Complications in General Plastic Surgery Procedures, Plastic and Reconstructive Surgery - Global Open, 9(8) 2021 August. doi: 10.1097/GOX.0000000000003744
Bloom, J., Foroutanjazi, S., Erlichman, Z., Beqiraj, Z., Jonczyk, M., Persing, S., Chatterjee, A. The Use of Hemostatic Agents to Decrease Bleeding Complications in Breast Cancer Surgery. The American Surgeon. 2021 June 27. doi: 10.1177/00031348211029866.
Char, S., Bloom, J., Erlichman, Z., Jonczyk, M.,Chatterjee, A. A comprehensive literature review of patient-reported outcome measures (PROMs) among common breast reconstruction options: What types of breast reconstruction score well? Breast Journal. 2021 Feb 9. doi: 10.1111/tbj.14186. PMID: 33565192.
Aalberg, J Jr., Erlichman, Z., Blank, M., Guo, L., Mackey, WC. Race-based disparities in presentation and outcomes in infrainguinal bypass patients. International Angiology. 2021 Apr;40(2):105-111. doi: 10.23736/S0392-9590.20.04481-8. 2020 Dec 14. PMID: 33315208.
Erlichman Z., Bloom J., Foroutanjazi S., Aalberg J Jr., Chatterjee A. Comparing outcomes of post-mastectomy breast reconstruction between United States and Western Europe✰. J Plast Reconstr Aesthet Surg. 2021 Mar;74(3):644-710. doi: 10.1016/j.bjps.2020.08.040. Epub 2020 Aug 21. PMID: 33268290.
Erlichman Z., Bloom J., Char S., Foroutanjazi S., Nardello S., Chatterjee A. Trends in Outcomes of Level 2 Volume Displacement in Oncoplastic Breast Surgery Between the United States and Western Europe. Am Surg. 2020 Nov 23:3134820954859. doi: 10.1177/0003134820954859. Epub ahead of print. PMID: 33228380.
Bloom, J. A., Erlichman, Z., Tian, T., Doron, S., Chen, L., Mansur, K., & Tarnoff, M. E. (2020). The prevalence of asymptomatic carriers of COVID-19 as determined by routine preoperative testing. Journal of Infection Prevention, 22(1), 7-11. doi:10.1177/1757177420967096
Capowski, E. E., Samimi, K., Mayerl, S. J., Phillips, M. J., Pinilla, I., Howden, S. E., Erlichman, Z .… Gamm, D. M. (2018). Reproducibility and staging of 3D human retinal organoids across multiple pluripotent stem cell lines. Development, 146(1). doi: 10.1242/dev.171686
Adeyeye, M., Gbadero, D., Farayola, L., Mckinley, V., Olalere, N., Erlichman, Z., Amosun, T. (2017). Evaluation of an Undocumented Polyherbal (Faradin®) Used for the treatment of sickle cell disease in West Africa. Part II: Antibacterial activity and synergism. Journal of Pharmaceutical Research International, 17(4), 1–11. doi: 10.9734/jpri/2017/33606